People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Eight countries now have substantial disruptions to antiretroviral (ARV) therapy and will run out of medicines in the coming ...

Weight trajectories differed significantly among patients with HIV during the first year of ART, with no associations observed between weight gain and type of ART regimen.

HIV infections are lifelong and can weaken the immune system, causing a patient to be more susceptible to infection and ...

Taimed Biologics Inc.’s TMB-365/TMB-380 long-acting combination of broadly neutralizing antibodies (bnAbs) regimen for HIV maintenance could reshape HIV treatment management, offering a viable ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC ...

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV.

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

SAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...